(3-((2-(Piperidin-1-yl)ethyl)carbamoyl)phenyl)boronic acid, 95.0%, 250mg

Volumetric flasks with glass stopper, class A Brown glass, 1000 ml, 24/26, 1 Piece

Cellotetraose>94.0%(HPLC)10mg

6-CHLORO-9-[3-(2-CHLOROETHYLAMINO)PROPYLAMINO]-2-METHOXYACRIDINE DIHYDROCHLORIDE, 95%, 25mg

5-BROMO-1-METHYLQUINOLIN-2(1H)-ONE, 95.0%, 250mg

4,4,5,5-Tetramethyl-2-(4-(2,5-dimethylpyrrol-1-yl)phenyl)-1,3,2-dioxaborolane, 98%, 250mg

3-chloro-5-cyclohexyl-1,2,4-thiadiazole, 95.0%, 500mg

N-(6-Bromo-1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-2,2,2-trifluoroacetamide, 98%, 1g

Melting point capillary, 75 mm, 1.55 mm, 1.15 mm, 1000 Piece(s)

N,N-Dimethyl-4-fluoro-2-nitroaniline, 95.0%, 25g

3-Bromo-N-methylpyridin-2-amine, 95.0%, 1g

1,5-Dimethoxynaphthalene, 95.0%, 5g

3-Fluoro-N,N-diethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 98%, 500mg